^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    sirolimus for injection (albumin-bound) (SRL-HSA)

    i
    Other names: SRL-HSA
    Associations

    News

    Trials
    Company:
    CSPC Pharma
    Drug class:
    mTOR inhibitor
    Related drugs:
    Associations

    News

    Trials
    3d
    A phase Ib/II clinical trial on the safety and efficacy of sirolimus (albumin-bound) combined with different ADCs in patients with advanced solid tumors (ChiCTR2500111937)
    P1, N=444, Not yet recruiting, Fudan University Shanghai Cancer Center; CSPC Zhongqi Pharmaceutical Technology Co., Ltd.
    New P1 trial
    |
    EGFR (Epidermal growth factor receptor) • CD276 (CD276 Molecule) • NECTIN4 (Nectin Cell Adhesion Molecule 4)
    |
    HER-2 negative • HER-2 expression • EGFR expression
    |
    sirolimus • trastuzumab envedotin (DP303c) • SYS6010 • sirolimus for injection (albumin-bound) (SRL-HSA)
    5ms
    Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (clinicaltrials.gov)
    P2/3, N=243, Recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    New P2/3 trial
    |
    everolimus • sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)
    9ms
    Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy (clinicaltrials.gov)
    P2, N=78, Active, not recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    New P2 trial
    |
    fulvestrant • letrozole • anastrozole • sirolimus • exemestane • sirolimus for injection (albumin-bound) (SRL-HSA)
    10ms
    Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors (clinicaltrials.gov)
    P3, N=312, Not yet recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    New P3 trial
    |
    fulvestrant • sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)
    over3years
    A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=270, Not yet recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
    New P1 trial
    |
    TSC2 (TSC complex subunit 2) • TSC1 (TSC complex subunit 1)
    |
    sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)